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Cloning and Analysis of Putative Collagenases of the U32 Family in 
Streptococcus mutans and Streptococcus agalactiae (Group B Streptococci) 
 
Valerie Carson 
 
ABSTRACT 
 
 
Analysis of the genomic sequences of Streptococcus mutans UA159 and 
Group B Streptococcus (GBS) strains Streptococcus agalactiae NEM316 and S. 
agalactiae 2603V/R indicated the presence of two putative collagenase genes in 
each organism.  smcol1 from S. mutans was previously cloned and analyzed and 
the results indicated that the enzyme belonged to the U32 family of 
collagenases/peptidases.  This enzyme shares homology with the prtC of 
Porphyromonas gingivalis, one of the principal examples of the U32 family of 
peptidases.  Considering the potential role of these enzymes in the pathogenicity 
of P. gingivalis (periodontitis or gum disease), GBS (premature rupture of the 
amniochorionic membrane) and S. mutans (dental root decay), it is necessary to 
study these enzymes and establish their role in the virulence of these organisms.  
Toward this goal the present study has focused on cloning collagenase 2 
(smcol2) from S. mutans and cloning collagenase 1 (gbscol1), and collagenase 2 
(gbscol2), from GBS.  The information obtained will contribute to a further 
understanding of the U32 peptidase family. 
 1
 
 
 
 
 
INTRODUCTION 
 
Collagen is a major structural protein in our bodies, making up a large 
percentage of human tissue, from the skin to the tendons, eyes, bones, amniotic 
membrane and teeth.  In the mouth, collagen is one of the main components of 
gingival connective tissue and it is found in the matrix of alveolar bone and 
cementum, dentin of the tooth and in the basement membrane beneath the 
gingival epithelium (37).  Periodontal tissue is made up primarily of type I 
collagen, which is made up of three parallel polypeptide chains composed of the 
sequence Gly-X-Y, with X representing proline and Y representing 
hydroxyproline.  These amino acids give collagen stability and restrict the rotation 
of the polypeptide backbone (10).  Collagen is extremely resistant to degradation 
because of its tightly coiled triple helix structure that is stabilized by hydrogen 
bonds and cross-linking and can only be cleaved by collagenases (20).   
Until recently it was thought that only a few species of bacteria produced 
collagenases, namely Clostridium and Vibrio alginolyticus, but numerous other 
human pathogens have also been reported to have the ability to break down 
collagen (17).  The specificity of bacterial collagenases is very broad and, unlike 
vertebrate collagenases that are more specific in their cleavage sites (33), 
bacterial collagenases are capable of hydrolyzing denatured as well as native 
collagen. Gelatin is produced when collagen loses its triple helix structure and 
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becomes denatured.  Numerous mammalian proteases are able to hydrolyze 
gelatin, including pepsin, trypsin and papain.  Hydrolysis of collagen may help in 
bacterial infection and spreading, hence collagenase has been considered as a 
virulence factor and the focus of numerous studies.   
 The most widely studied collagenase is a metalloprotease produced by 
Clostridium histolyticum (32) that requires a zinc molecule to retain its hydrolytic 
activity (47).  This zinc-metalloprotease is unique in that it is able to cleave 
denatured and native collagen (32). Subsequently, C. histolyticum has been 
found to produce different types of collagenases, which are separated into two 
classes based on their amino acid sequences and peptide substrate 
requirements (31).  C. histolyticum colH is a 116 kDa collagenase that co-purifies 
with a 98 kDa protein, which cleaves denatured collagen, but not native collagen 
(47).  Because they share identical N-terminal sequences and peptide maps, it is 
believed that the 98 kDa gelatinase is produced by the cleavage of the C-
terminal end of the 116 kDa collagenase (32).  C. histolyticum also produces 
another collagenase, ColG.  It was found that colG and colH are less than 760 kb 
apart on C. histolyticum’s genome.  It is hypothesized that the presence of these 
similar clostridial collagenase genes is due to gene duplication and later 
divergence (31). 
Periodontitis is a collection of diseases involving the  destruction of structural 
proteins in the oral cavity (37) . Periodontal diseases, which are characterized by 
the destruction of collagen, vary in severity depending on the stage of 
development, age of the patient and reaction to treatment. Degradation of 
 3
gingival connective tissue, the supporting structure of the tooth, including type I 
collagen, leads to periodontal lesions.  Numerous studies have shown that in 
regions of periodontal tissue degradation, extensive collagenase activity is 
evident (38).  Collagenase activity by bacteria of the oral cavity were first 
discovered in the 1960’s (17).  Hence, an understanding of how bacteria interact 
with collagen of the periodontium is a necessary tool in the understanding of their 
pathogenecity.   
A common bacterium isolated from infected individuals suffering from 
advanced periodontitis is Porphyromonas gingivalis (27). This organism has 
collagenases, one of which is encoded by prtC. The  prtC enzyme was found to 
be able to break down soluble type I collagen (38), as well as fibrillar collagen; 
however it could not degrade the synthetic collagenase substrate, PZ-PLGPA, 
gelatin nor denatured type I collagen (27).  The ability of P. gingivalis to cleave 
native type I collagen was eliminated by the inactivation of one of the two genes 
encoding Arg-gingipain A or B (20), suggesting that the collagenase activity of P. 
gingivalis requires the action of both enzymes (27).  It was also found that the 
activity of these two enzymes is dependent on their association with the bacterial 
cell wall, given that  purified enzymes showed no activity  (20).  Indeed, prtC was 
classified in the U32 family of peptidases/collagenases based on the presence of 
a consensus sequence. 
One of the most widespread and expensive infectious diseases in the world is 
dental caries (11), of which S. mutans is the primary etiological agent.  It has 
been found that if oral streptococci are inhibited on the root surface, the 
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development of dental caries is greatly diminished (40).  Dental caries results 
from the acidic end products produced by the metabolism of fermentable 
carbohydrates in the diet.  This drastically decreases the pH in the oral cavity 
which leads to the dissolution of the tooth enamel and root surface (45).    Dental 
caries is a public health problem world-wide, hence extensive research effort has 
focused on developing means to prevent this infectious disease.  Kassab et al, 
determined that approximately 24 million people in the United States have tooth 
surfaces that have 3 millimeters or greater of gingival recession and that the 
occurrence of gingival recession increased with age and was higher in men 
compared to women of the same age (26).  Fluoridation of water and dental 
hygiene showed limited success.  With current medical research, the average life 
span has greatly increased, but along with this, the occurrence of dental root 
decay has also increased.   
Dentin, unlike the tooth crown, is made up of organic components and 
hydroxyapatite, an inorganic material (10).  The organic component of dentin is 
composed of about 90% type I collagen, citrate, lipids and non-collagenous 
proteins. Root caries begin by exposure of the root surface to the oral 
environment via recession of the gum and subsequently the exposed dentin 
becomes vulnerable to microbial infection, which can lead to loss of the tooth 
(10).  Gingival recession, which is defined as the dislocation of the gingival tissue 
and exposure of the root, can be localized or generalized (26). It has recently 
been shown that greater than 50% of the general population had one or more 
locations with gingival recession of 1 millimeter or greater. Many factors are 
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associated with gingival recession, including age, lack of alveolar bone, the 
abnormal tooth position, and vigorous tooth brushing (26).  The main factors 
involved in the progression of root caries is the invasion of bacteria into the 
dentin and fermentable carbohydrates derived from the host’s diet (5).   
Development of root and coronal caries differs greatly.  Root caries involve 
the decomposition of dentin minerals while coronal caries involves enamel 
demineralization.  Root surface caries seem to be more complex in their 
treatment and pathology as compared to coronal caries although both types of 
caries involve acidic demineralization  (10). The rate at which coronal and root 
caries proceeds also differs.  The destruction of dentin transpires about twice as 
quickly as the demineralization of the enamel, due to the fact that the crown is 
composed of almost double the amount of minerals (5).   
One study showed that the microflora that colonized isolated dentin 
specimens from patients were composed of a diverse community of bacteria 
(41).  Numerous microorganisms have been isolated from root caries lesions 
including, Actinomyces spp, Streptococcus spp, and Lactobacillus spp (3).  It has 
been found that Actinomyces and Streptococcus where the dominant species 
isolated from root surface lesions (41).  S. mutans is routinely found in root caries 
plaque samples and has been shown to be one of the major players in root 
caries disease (3).  It has also been found that the inhibition of streptococci at the 
root surface leads to the decline of root caries (42).  S. mutans produces a 
number of proteins that are associated with its cell wall and have been implicated 
as virulence factors, hence they are the focus of research regarding S. mutans 
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and dental caries (15, 40). Antibodies against these antigens could possibly 
thwart the development of dental caries by S. mutans.   The main objective for an 
anti-dental caries vaccine would be to prevent S. mutans from attaching and 
adhering to oral tissues, which could lead to the prevention of tooth decay on the 
surface and root of the tooth.  With the increasing technology in recombinant 
DNA techniques, research has focused on identifying and isolating genes 
involved in the pathogenicity of S. mutans.  Numerous genes that are involved in 
coronal caries, such as polymer-forming glucosyltransferases, fructosyl-
transferases, and wall associated protein A have been cloned and sequenced 
(12, 45).  In studies where cell wall fractions were exposed to proteases, animals 
that were immunized with the suspension were not protected against dental 
caries (13).  Indeed, the identification of these cell-surface proteins as potential 
immunogens against dental caries should be further investigated.   
Degradation of collagen in tissues of the dento-epithelial seam leads to the 
development of a region that has a redox potential level that is lower than that of 
the surrounding tissue (17).  This environment promotes the colonization of 
anaerobic organisms which can lead to periodontal disease.  Infection with S. 
mutans has been shown to degrade the periodontal ligament, instigate the 
massive loss of bone, while the production of collagenase activity in this 
organism was substantiated by its ability to hydrolyze collagen fibrils in rat tail 
tendons (17, 18).  S. mutans has been found in human root surface carious 
lesions and is able to bind collagen type I and II (22).  S. mutans has been shown 
to possess two extracellular proteases that can hydrolyze PZ-PLGPA and 
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breakdown type I collagen (18).  It is speculated that these enzymes may be a 
factor in the degradation of collagen of the dentin and cementum of the oral 
cavity (17).   Switalski et al. (42) found that S. mutans was able to bind collagen 
in dentin and that it may have a profound effect on the development of root 
surface caries.  It was also demonstrated that S. mutans strain GS-5 was 
capable of breaking down alveolar bone and collagen of the periodontal ligament 
(18).  Jackson et al. demonstrated cell-associated collagenase activities in S. 
mutans (22).  It was found that S. mutans was able to bind collagen and that cell 
lysate from S. mutans cross-reacted with antiserum to collagenase from C. 
histolyticum (22).  These characteristics taken together lend to the fact that S. 
mutans plays a considerable role in the pathogenesis of dentinal caries.  These 
virulent factors may aid S. mutans in maintaining its environmental niche in the 
oral cavity and contribute to its ability to cause host tissue damage.   
A great deal of focus has been directed on producing a vaccine against 
coronal caries (16, 24), but this will have no effect on the colonization of dental 
root by S. mutans and subsequent destruction of the root dentine.  While coronal 
caries involves surface adhesins with binding affinity for salivary pellicles and 
glucan-binding proteins (42), dental root decay is mediated by collagen-binding 
protein and collagen degrading enzymes.  More research is needed in order to 
identify and characterize the factors involved in dental root caries in order to 
develop specific prophylactic measures. 
Streptococcus agalactiae, also referred to as Group B streptococci (GBS), is 
the leading cause of severe neonatal bacterial infections, including pneumonia, 
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sepsis and meningitis.  In the United States, about 10,000 instances of GBS 
infections occur with a 15% mortality ratio (28, 36), being responsible for two to 
three cases per 1000 live births (14).  GBS can be found living asymptomatically 
in the vaginal epithelium and the lower gastrointestinal tract of healthy adults.  
GBS has a competitive advantage over other microflora in the vaginal epithelium 
since it is able to attach to the epithelium and survive in the low pH environment.  
It is estimated that 10-40% of women who are pregnant are infected with GBS 
and that 40-70% of these women transmit the bacterium to their child (7).  
Human newborns contract GBS when they pass through the birth canal or 
swallow infected amniotic fluid from their mother (30).  GBS does not only infect 
neonates and pregnant women, it also affects people with chronic conditions and 
the elderly.  The incidence of invasive GBS infections has steadily increased in 
recent years for the immunocompromised and the elderly to numbers similar to 
the incidence of the newborn population (30).  Most newborn that become 
infected with GBS do not develop disease, but the range of virulence factors 
attributed to GBS can lead to infection when the infant’s immune system fails.  
These virulence factors include its ability to hinder the newborns defensive 
system, factors that allow the organism to infect the bloodstream and deep tissue 
by its ability to invade the epithelial and endothelial barriers, the production of 
toxins, and mechanisms that allow inflammatory reactions in the host (30).  When 
an infant is born prematurely, the likelihood that the infected newborn will 
become symptomatic is greatly increased.  Generally, 1-3% of infected babies 
develop early-onset disease (sepsis and meningitis) within the first 24 hours after 
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birth (7).  It has been suggested that vaginal infection or inflammation is linked to 
preterm rupture of the amniotic membrane and preterm labor (44).  Labor before 
37 weeks gestation is considered preterm labor (PTL) and delivery (PTD) and is 
usually preceded by pre-mature rupture of membranes (PPROM) (39).  PTL and 
PTD is generally caused by such factors as: smoking, alcoholism, poor nutrition, 
health disorders, PROM, multiple gestation, placental abruption and bacterial 
infection (39).  The main cause of PPROM and PTL can be contributed to 
bacterial infections (39).  About 12% of pregnancies in 2001 were caused by 
preterm birth, with the number of preterm babies being born progressively 
increasing (39).   In premature labors, it has been found that there is a decreased 
concentration of collagen (44).  The fetal membrane is composed of collagen 
types I, III, and V (2), with type I and type V giving the amniotic membrane its 
strength (35).   
It is hypothesized that GBS may be involved in the premature rupture of the 
amniotic tissue based on the fact that infection with this organism was associated 
with the degradation of the amniochorionic membrane and on its ability to 
degrade the synthetic peptide FALGPA, which mimics collagen (23).  However, it 
was found that GBS was incapable of degrading a film of reconstituted rat tail 
collagen (30). Lin et al. (29) further isolated and tested the suspected 
collagenase and speculated that it was not a collagenase but an oligopeptidase, 
belonging to the M3 oligopeptidase family of metallopeptidases.  Since the paper 
has been published, two strains of S. agalactiae, 2603V/R (43) and NEM316 
(14), have been sequenced and submitted online at www.ncbi.nlm.nih.gov.  
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Based on sequence analysis of both strains, it was found that S. agalactiae does 
indeed have a gene (gbs0824 from strain NEM316 and SAG0805 from strain 
2603V/R) similar to pepF from Lactococcus lactis (66.4% identity, data not 
shown), which is also an M3 oligopeptidase and displayed many of the same 
properties as members of this family.  
Peptidases are categorized into clans and families where clans represent sets 
of families that share common ancestry and families are arranged by their 
catalytic specifications.  The peptidase clan U- belongs to MEROPS peptidase 
family U32 of the clan U- and has an unknown catalytic mechanism.  It also 
contains the consensus pattern: E-x-F-x(2)-G-[SA]-[LIVM]-C-x(4)-G-x-C-x-[LIVM]-
S.  The most studied peptidase of this family is the prtC collagenase from 
Porphyromonas gingivalis, which is capable of degrading type I collagen and 
may require a metal cofactor.  It is able to degrade soluble type I collagen but not 
gelatin or synthetic collagenase substrates.   
The availability of sequenced genomes online has allowed a more thorough 
search and analysis of bacterial genomes.  And with the convenience of 
molecular genomics, such as PCR and cloning into expression vectors, it is now 
possible to easily and efficiently study virulence factors from pathogens.  
Recently, our lab has isolated and characterized a collagenase gene (smcol1) of 
the U32 peptidase family from S. mutans (Ioannides, Biology MS thesis, USF, 
2004). smcol1 was cloned and expressed in Escherichia coli and the 
recombinant protein was purified and studied.  The smcol1 was shown to be 
identical to the SMU.761 protease in S. mutans UA159.  
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 Preliminary analysis of the S. mutans UA159 indicated the presence of 
another putative collagenase (col2) encoded by a gene upstream from smcol1 
(SMU.759).  Similar enzymes to S. mutans col1 and col2 were also identified in 
the analysis of GBS NEM316 and 2603V/R genomic sequences (gbs0762 and 
gbs0763 in GBS NEM316, and SAG0741 and SAG0742 in strain 2603V/R). The 
goal of the present study was to clone smcol2, gbscol1 and gbscol2 into E. coli 
TOP10 using the arabinose-inducible expression vector system pBAD TOPO® 
TA (Invitrogen), which allows the expression and purification of soluble 
recombinant His-tagged protein. Recombinant proteins will be analyzed for 
collagenase and gelatinase activity.  The results obtained in the present studies 
will add to our understanding of S. mutans and GBS role in their respective 
pathogenicity. 
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MATERIALS AND METHODS 
 
 
Chemicals and Reagents 
 
Primers for PCR were produced by Operon Biotechnologies (Huntsville, 
AL).  PCR reagents, restriction enzymes, The Wizard® Genomic DNA 
Purification Kit and The Wizard® Plus Minipreps Plasmid DNA Purification 
System were obtained from Promega Inc. (Madison, WI) and used in accordance 
to the manufacturer’s protocols.  The expression vector, pBAD TOPO® TA was 
obtained from Invitrogen Life Technologies (Carlsbad, CA). All other reagents 
and chemicals were purchased from Sigma-Aldrich Co. (St. Louis, MO), Fisher 
Scientific (Pittsburg, PA), or Bio-Rad Laboratories (Hercules, CA) unless 
otherwise specified. 
 
Bacterial Strains and Growth Conditions 
S. mutans GS-5 serotype c, was initially obtained from J. J. Ferretti 
(University of Oklahoma Health Sciences Center, Oklahoma City, OK). GBS 
USF704 (serotype Ib/c, α, β, γ) is a β-hemolytic clinical isolate originally obtained 
from a septic newborn and was acquired from Dr. Daniel Lim (University of South 
Florida Department of Biology and Center for Biological Defense, Tampa, FL). 
Both strains were cultured at 37ºC in BHI broth with 5% CO2.  Chemically 
competent E. coli TOP10 cells were obtained from Invitrogen and used in the 
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cloning and expression of all recombinant plasmids.  Luria-Bertani (LB) medium 
(Difco, Detroit, MI) containing 100 µg/ml ampicillin (LBA) was used in the 
selection of transformants and the culturing of recombinant clones expressing the 
collagenase genes. 
 
Bioinformatical Analysis 
The sequences used for the cloning and analysis of the collagenase 2 gene 
(smcol2) from S. mutans and the collagenase 1 (gbscol1), and collagenase 2 
(gbscol2) genes from GBS were obtained from the National Center for 
Biotechnology Information (NCBI) Entrez server.  The sequenced genomes of S. 
mutans UA159 (Accession # AE0141) and S. agalactiae NEM316 serotype III 
strain (Accession # AL732656) and S. agalactiae 2603V/R serotype V 
(Accession # AE009948) were used for the genomic analysis of the 
collagenases.  Alignment analysis was performed using the ClustalW WWW 
Service at the European Bioinformatics Institute (19).  Signal peptide analysis 
was derived from PSIPRED Protein Structure Prediction Server (25, 34). 
 
Isolation of Genomic DNA 
The isolation of genomic DNA was accomplished using a genomic DNA 
purification kit (Promega’s Wizard®).  The isolation was performed according to 
the manufacturer’s protocol.  Briefly, 1 ml from an overnight culture was 
centrifuged at 16,000 x g for 2 minutes and the supernatant removed.  The cell 
pellet was resuspended in 480 µl of 50 mM EDTA.  120 µl of 10 mg/ml of 
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lysozyme was added to the cell suspension and incubated at 37°C for 1 hour to 
weaken the cell wall.  The samples were centrifuged at 16,000 x g for 2 minutes.  
The supernatant was removed and 600 µl of Nuclei Lysis Solution was added to 
the samples and incubated at 80°C for 5 minutes to lyse the cells.  The solution 
was cooled to room temperature.  3 µl of RNase Solution was added to the cell 
lysate and incubated at 37°C for 45 minutes.  200 µl of Protein Precipitation 
Solution was added to the RNase-treated cell lysate and incubated for 5 minutes 
on ice.  The samples were then centrifuged at 16,000 x g for 3 minutes.  The 
supernatant containing the DNA was transferred to a clean 1.5 microcentrifuge 
tube and 600 µl of room temperature isopropanol was gently mixed with the 
DNA.  The mixture was centrifuged at 16,000 x g for 2 minutes.  The supernatant 
was gently aspirated off and 70% ethanol was added to the pellet.  The 
suspension was again centrifuged at 16,000 x g for 2 minutes and the ethanol 
aspirated.  The pellet was allowed to air dry for 3 hours and 100 µl of DNA 
Rehydration Solution was added to rehydrate the DNA pellet.  The purity and 
concentration of the DNA was determined by analysis on a 1% agarose gel and 
measurement on the SmartSpec Plus Spectrophotometer (Bio-Rad        
Hercules, CA). 
 
PCR Amplification of S. mutans and S. agalactiae Genomic DNA 
Using purified genomic DNA from S. mutans GS-5 as a template, PCR was 
performed to amplify the collagenase 2 gene (smcol2).  Primers were designed 
based on the sequenced genome of S. mutans UA159 (9).  Four primer sets 
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were developed to amplify the gene with and without the signal peptide.   The 
gene was also amplified with and without the native stop in order to include the 
V5 epitope and the polyhistidine region of the pBAD vector. PCR was performed 
using four different primer sets (Table 1) to amplify the smcol2 gene from S. 
mutans GS-5 genomic DNA under the following conditions: an initial denaturation 
step at 95ºC for 2 minutes.  Then 30 cycles of the following: 95ºC for 1 minute 
(denaturation step), 1 minute at the corresponding annealing temperature for the 
specific primer (annealing step), and 72ºC for 1 minute (extension step).  Lastly, 
a final extension step was done at 72ºC for 10 minutes.  The PCR mixture used 
contained the following:  12.5 µl of PCR Master Mix (Promega), 0.2 µM of the 
forward primer, 0.2 µM of the reverse primer, 25 ng of genomic DNA, and 10.5 µl 
of H2O.  The PCR products were analyzed by electrophoresis on a 1% agarose 
gel.  The DNA was stained with ethidium bromide and viewed under ultraviolet 
light.   
smcol2 
Clones
Forward 
Primer
 Reverse Primer  Annealing 
Temp
Clone 1 Includes the 
signal peptide 
5’ATGGAAAAAA
TTGTTATCACT
GCGACTGC 
Contains native 
stop 
5’TTACTTAAC
TGTTTGCGG
ATCAAGC 
55.0ºC 
Clone 2 Includes the 
signal peptide 
5’ATGGAAAAAA
TTGTTATCACT
GCGACTGC 
Does not contain 
native stop 
5’CTTAACTGT
TTGCGGATC
AAGC 
56.8ºC 
Clone 3 Excludes the 
signal peptide 
5’AATATTAAAC
CATTTTTAGAA
TTAATGAAGGA
AATTCAG 
Contains native 
stop 
5’TTACTTAAC
TGTTTGCGG
ATCAAGC 
55.4ºC 
Clone 4 Excludes the 
signal peptide 
5’AATATTAAAC
CATTTTTAGAA
TTAATGAAGGA
AATTCAG 
Does not contain 
native stop 
5’CTTAACTGT
TTGCGGATC
AAGC 
55.4ºC 
 
Table 1.  PCR primers used in the amplification of smcol2  
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The sequences for genes SAG0741, SAG0742, gbs0762 and gbs0763 of 
S.agalactiae 2603V/R (43) and S. agalactiae NEM316 (14), respectively, were 
used to develop primers for the gbscol1 and gbscol2 genes. The reason for this 
selection is based on the highest homology each one has with the corresponding 
enzyme in S. mutans.  
SAG0742 and gbs0763 were used to design primers for gbscol1  
Forward = 5’ ATGTCTAATGTAAAAAAACGCCCT 
Reverse = 5’ AGCTCTTACAGTCTTGCTAG 
SAG0741 and gbs0762 were used to design primers for gbscol2  
Forward = 5’ ATGGAAAAAATAATTTTGACAGCGAC 
Reverse = 5’ TTTTACTGTTGATGGGTCAAAATC 
PCR conditions were optimized for the specific primers and the conditions 
were as described above.   The specific annealing temperature for the gbscol1 
primers was 52.7ºC and 51.6ºC for gbscol2 primers (Operon Biotechnologies).  
 
Cloning of the smcol2, gbscol1 and gbscol2 Genes into the pBAD-TOPO® 
TA Vector 
Once the correct size of the PCR products was verified on a 1% agarose gel, 
the products were cloned into the pBAD TOPO® TA vector (Figure 1).  Briefly, for 
the cloning reaction, 2 µl of fresh PCR product was mixed with 1 µl of pBAD 
vector, 1 µl of salt solution (1.2 M NaCl and 0.06 M MgCl2) and 1 µl of H2O and 
allowed to incubate at 24ºC for 5 minutes.  The cloning mixture was then placed 
on ice and 2 µl was mixed with 250 µl of One Shot® TOP10 Chemically 
Competent E. coli cells (Invitrogen).  The cells were incubated on ice for 15 
minutes.  Transformation was by heat shock treatment: 30 seconds in a 42ºC 
water bath followed by immediate cooling on ice.  250 µl of S.O.C. medium 
(Invitrogen) was added to the cells and they were horizontally incubated at 37ºC 
for one hour with shaking.  Finally, 20 µl and 40 µl samples were cultured on pre-
warmed LBA plates.  The plates were incubated for 24 hours at 37ºC.  After 
incubation, five ampicillin resistant (AmpR) clones from each cloning reactions 
were chosen at random for further screening of each gene. 
 
 
 
Figure 1.  Map of the expression vector pBAD TOPO® TA (Invitrogen) 
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Analysis of the Recombinant Plasmids  
Plasmid DNA was isolated from the clones using the FastPlasmid™ Mini kit 
from Eppendorf (Westbury, NY) following the manufacturer’s protocol.  Briefly, 
the AmpR transformants containing the recombinant plasmids were grown in LBA 
for 16 hours at 37ºC with shaking.  1.5 µl of each culture was centrifuged at 
16,000 x g for 1 minute and the supernatant was removed.  400 µl of the Lysis 
Solution was added to the pellet and resuspended with vigorous mixing.  The 
mixture was then incubated for 3 minute at 24°C. The lysate was removed and 
transferred to a spin column assembly that was then centrifuged for 1 minute at 
16,000 x g. The spin column assembly was washed with 400 µl of diluted wash 
buffer and centrifuged for 1 minute. The solution in the bottom of the tube was 
decanted and the spin column assembly was centrifuged for an additional minute 
to remove any excess isopropanol from the assembly. The spin column was then 
transferred to a clean tube and the plasmid DNA was eluted off by adding 30 µl 
of elution buffer and centrifuging at 16,000 x g for 1 minute. 
The presence of the inserts was verified by PCR using the reverse and 
forward primers specific for each clone. Once the insert was confirmed to be 
present, clones that were positive for the insert were analyzed to determine that 
the PCR product had been inserted in the correct orientation and was in frame 
with the C-terminal histidine residues.  To test for this, the pBAD Forward primer 
(5’ ATGCCATAGCATTTTTATCC) was used with the specific insert’s reverse 
primer.  Use of the pBAD Forward primer adds 179 bp to the PCR product.  Once 
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the PCR had been verified by electrophoresis of the PCR product on an agarose 
gel, one of the clones producing a band of the correct size was chosen and 
stored frozen in glycerol at -80°C as the laboratory stock strain. 
 
Expression of the Recombinant Proteins 
Pilot expression experiments were performed on pBAD/smcol2 clones #2 and 
#4, pBAD/gbscol1, and pBAD/gbscol2 to determine the optimal concentration of 
arabinose for induction of the clones and the expression of the recombinant 
proteins.  pBAD/smcol2 clones # 2 and # 4 were chosen for further analysis since 
they allowed for the production of the polyhistidine (6x) fusion protein tag, with 
and without the signal peptide, respectively.  They were further termed 
pBAD/smcol2sp, pBAD/smcol2wosp, respectively.  pBAD/smcol2 clones #1 and 
#3 were prepared in prevision of potential problem with enzyme activity being 
influenced by the polyhistidine fusion protein tag (since this problem did not 
occur, these two clones were not analyzed further).  The expression experiment 
was done according to the manufacturer’s protocol.  Briefly, the recombinant 
clones were inoculated into 2 ml of LBA broth (100 µg/ml ampicillin) and grown 
for 24 hours at 37ºC with constant shaking.  The following day, 0.1 ml of the 
overnight cultures was added to 10 ml of LBA and allowed to continue incubating 
at 37ºC with constant shaking.  The cultures were allowed to grow to an OD600 of 
0.5, approximately 2.5 hours.  A 1 ml sample of each culture was taken and the 
cells were sedimented by centrifugation.  The supernatant was aspirated and the 
pellets were frozen for a zero time point sample.  For each clone, cultures were 
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induced at five different concentrations of L-arabinose:  0.2%, 0.02%, 0.002%, 
0.0002%, and 0.00002%.  Un-induced cultures were also grown that did not have 
L-arabinose added to it.  The cells were then allowed to grow for an additional 4 
hours at 37ºC with constant shaking.  Each culture was centrifuged to pellet the 
cells.  The supernatant was aspirated and the samples were frozen for further 
analysis.  
 
SDS-PAGE Analysis of Gene Expression in Recombinant E. coli 
To determine if the recombinant bacteria produced the protein of interest, the 
samples obtained above were analyzed by electrophoresis on a 10% SDS-
Polyacrylamide gel (1 mm).  The cell pellets were thawed, resuspended in 20 µl 
of 1x SDS-PAGE Sample Buffer (Bio-Rad) and boiled in a water bath for 5 
minutes.  The samples were then separated by electrophoresis using a Mini-
Protean II Electrophoresis Cell (Bio-Rad) at 200V for 1 hour.  Once the samples 
were separated through the gel, the gel was stained with 0.1% Coomassie blue 
R-250 (in 40% methanol and 10% acetic acid) for one hour, then was destained 
by incubation in a destaining solution (40% methanol and 10% acetic acid).  
Numerous washes were used to totally destain the gel and obtain sharp protein 
bands stained in blue. 
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Western Blot Analysis of His-Tagged Fusion Protein 
A Western immunoblot was performed by separating the samples by SDS-
PAGE and then transferring them to a nitrocellulose membrane.  The proteins 
were transferred to the nitrocellulose for one hour at 30V and 100 mA, with an ice 
pack and constant stirring of the buffer using a Mini Trans-Blot® electrophoretic 
transfer cell (Bio-Rad).  The membrane was then blocked for 16 hours in 10 ml of 
Western Blot Blocking Solution (5% dry milk in PBS containing 0.05% Tween 20 
with) with gentle agitation.  Next, the membrane was washed twice with 10 ml of 
Western Blot Wash Buffer (PBS and 2% Tween 20) for 10 minutes each wash.  
The primary antibody, murine anti-HisG (Invitrogen), was diluted 1:5000 in 
Blocking Solution and incubated with the nitrocellulose for one hour at 24ºC with 
gentle agitation.  The antibody was washed away with two washes of Wash 
Buffer, 10 minutes each wash.  Next, the membrane was incubated with the 
secondary antibody, anti-mouse IgG antibody (Sigma) diluted 1:30,000 in 
Blocking Buffer, for one hour at 24ºC with gentle agitation.  The membrane was 
washed again with Wash buffer, twice for 10 minutes each wash and then 
developed.  The nitrocellulose was developed via Dao’s method (8).  Briefly, the 
membrane is incubated with sodium borate buffer (60mM sodium tetraborate, 
10mM magnesium sulfate, pH 9.7) containing 0.025% of O-dianisidine and 
0.025% of β -naphthyl acid phosphate.  After a 1 hour incubation in the buffer, 
the membrane was fixed by incubating in Immunoblot Fixing Buffer (methanol: 
H2O: acetic acid, 4:5:1).  The membrane was then rinsed in deionized water and 
allowed to dry. 
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Purification of Recombinant Proteins  
A fresh culture of the clones from the glycerol frozen stock was streaked onto 
LBA plates and grown for 24 hours at 37ºC.  A culture of competent cells that 
contained the empty pBAD vector was used as a negative control.  The 
recombinant clones were grown and induced as described above using the 
optimal concentration of arabinose.  The fusion proteins were purified using 
Qiagen’s Ni-NTA Fast Start Superflow Columns.  Purification was performed 
under native conditions and as described by the manufacturer.  The cell pellet 
was resuspended in 10 ml of native lysis buffer, containing lysozyme and 
benzonase and incubated on ice for 30 min. The lysate was centrifuged at 
14,000 x g for 30 minutes at 4°C to pellet the cellular debris.  The Fast Start 
Columns were drained of the shipping buffer and the supernatant containing the 
soluble fraction of the recombinant protein was applied to the column.  The 
column was washed twice with 4 ml of Native Wash Buffer.  The bound 6x His-
tagged protein was eluted out with two 1 ml aliquots of Native Elution Buffer.  The 
samples were analyzed by SDS-PAGE and Western Blot as described above.  
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Protein Concentration 
The protein concentration of all samples were determined by the BCA Protein 
Assay developed by Bradford (4).  Briefly, a serial dilution of Bovine Serum 
Albumin (BSA) was prepared and assayed along with the samples to be tested. 
After addition of the BCA Working Reagent (Sigma) to the samples, they were 
incubated for 15 minutes at 60°C and the absorption was read at OD595.  The 
values obtained from the BSA were used to develop a standard curve, which was 
used to determine the protein concentration of the test samples. 
 
Gelatinase assay 
      X-ray film coated with gelatin was stained with Coomassie blue R250, and 
used to assay for gelatinase activity.  Ten µl of each purified sample obtained 
above was dotted onto the stained X-ray film, which was then placed in a humid 
chamber (box with a piece of wet paper towel placed at the bottom).  Incubation 
was at 37oC for 16 hours, at which time the film was placed under running faucet 
water.  Dots containing digested gelatinase were identified by a cleared zone 
exposing the shiny film backing.   
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Collagenase Assay 
Controls for the collagenase assay included C. histolyticum collagenase as a 
positive control and trypsin as a negative control.  Purified SmCol2 with or 
without the signal peptide, GBSCol1 with the signal peptide and GBSCol2 with 
the signal peptide were prepared as follows: The samples were prepared by 
growing 30 ml cultures for 24 hours at 37°C.  The following day, the cells were 
pelleted and the supernatant removed.  The pellet was resuspended in 5 ml of 
Gelatinase Assay Buffer (GAB: Tris-HCl with CaCl2 at pH 7.4) and freeze-thawed 
3 times on dry ice and a 42°C water bath.  The cells were then sonicated with 
short bursts and centrifuged at 8,000 X g for 25 minutes.  The supernatant was 
poured off into clean tubes and the pellet was resuspended in 5 ml of assay 
Buffer (50mM Tris buffer, 5 mM CaCl2 added at 5mM, pH 7.4).  Purified fusion 
proteins were isolated as described above and assayed for collagenase activity 
using a specific blue collagenase substrate developed in our laboratory (Dao, 
unpublished method).  Briefly, 100 µl of each sample (each sample was 
approximately 600 µg/ml) were incubated separately with 1 ml suspension of 
approximately 15 mg blue collagen type I from bovine tendon in assay buffer. 
The enzymatic assay using blue collagen was referred to as “blue collagenase 
assay” (proprietary method).  After incubation in an incubator shaker at 37oC, 
followed by centrifugation, degradation of collagen resulted in the blue coloration 
of the supernatant, which was quantified by measuring the absorbance of the 
blue dye at 500nm (OD500nm) using a spectrophotometer.   
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RESULTS 
 
 
Comparative Analysis between Putative Collagenase Genes of S. mutans 
and GBS 
The completed genomes of S. mutans UA159 (9), S. agalactiae strain 
NEM316 serotype III (14) and S. agalactiae strain 2603V/R serotype V (43) have 
been sequenced and, hence were used for this study.  Analysis of the genomic 
sequence of S. mutans UA159 revealed two proteases related to collagenase 
(SMU.759 and SMU.761).  These genes were used to find similar genes in 
Group B streptococci and compare their sequences with other known 
collagenases from C. histolyticum and P. gingivalis.  A BLink ("BLAST Link") was 
performed using SMU.759 and SMU761 sequences.  It was found that SAG0741 
from S. agalactiae 2603V/R showed the highest similarities with SMU.759 (78% 
homology, Figure 3) and SAG0742 from S. agalactiae 2603V/R showed the 
highest similarities with SMU.761 (78% homology, Figure 2).  These genes were 
used for further analysis.  SMU.761 was found to be 100% identical to smcol1, 
cloned recently in our lab from GS-5 (NCBI Accession # AY644675) (21).  
SMU.761 will be termed smcol1 and SMU.759 will be termed smcol2 for the 
remainder of this study.  The most closely related genes were selected for further 
analysis (Table 2).   
 
 26
 
Alignment Analysis 
Comparative analysis of the deduced amino acid sequence of the genes of 
interest was done using the alignment program, ClustalW WWW Service at the 
European Bioinformatics Institute (6) (Table 2).  SMU.761 (smcol1) showed high 
homology to SAG0742 from S. agalactiae 2604V/R (78%) and gbs0763 from S. 
agalactiae NEM316 (78%) (Figure 2).  Minimal similarity was observed between 
smcol1 and colG (2%) or colH (2%).  SMU.759 (smcol2) was found to have 
significant similarities with SAG0741 from S. agalactiae 2604V/R (77%) and 
gbs0762 from S. agalactiae NEM316 (78%) (Figure 3), Minimal similarity was 
found to colG and colH, 7% and 5% respectively.  Only 9% homology was 
observed between smcol2 and smcol1. 
Based on the sequence alignment, it was found that S. agalactiae 2603V/R 
and S. agalactiae NEM316 presented parallel results with the sequences used 
(Figure 2 and 3).  Hence, SAG0742 and gbs0763 were determined to be the 
same gene, as SAG0741 and gbs0762.  They were termed gbscol1 and gbscol2, 
respectively. 
Organism Gene Protein Function
Streptococcus mutans UA159 SMU.759 Putative collagenase
Streptococcus mutans UA159 SMU.761 Putative collagenase
Streptococcus agalactiae 2603V/R SAG0742 Peptidase, U32 
Streptococcus agalactiae NEM316 gbs0763 Hypothetical protein
Streptococcus agalactiae 2603V/R SAG0741 Hypothetical protein
Streptococcus agalactiae NEM316 gbs0762 Hypothetical protein
Clostridium histolyticum colH Collagenase 
Clostridium histolyticum colG Collagenase 
Porphyromonas gingivalis prtC Collagenase 
 
Table 2.  Genes selected for further bioinformatical analysis. 
Alignment Scores for smcol1
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Figure 2.  Alignment of homology for smcol1 
 
 
Alignment Scores for smcol2
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Figure 3.  Alignment of homology for smcol2 
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Figure 4.  Phylogram.  Estimated phylogeny between the selected genes.  
Branch lengths are proportional to the amount of inferred evolutionary change. 
 
 
 
Tables of Homology 
The sequence of smcol2, gbscol1 and gbscol2 was used as a query to 
identify homologous genes in other bacteria and to deduce the corresponding 
amino acid sequence and associated biochemical characteristics.  The BLAST 
analysis indicated high homology with the U32 family of peptidases and 
collagenases of other related organisms (Tables 4, 5, and 6). 
 By using the S. mutans UA159 smcol2 sequence as a query, a BLAST 
search showed 197 hits to 119 unique species (Table 3).  Analysis of the 
deduced amino acid sequence showed notable homology with Streptococcus 
suis collagenase (79%), Streptococcus pyogenes putative protease (77%) and S. 
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pyogenes peptidase family U32 (76%).  It also showed homology to U32 
peptidases of Enterococcus faecalis (53%) and Bacillus anthracis (31%). 
 Using the gbscol1 sequence as a query, a BLAST analysis was done to 
determine which genes carried the most homology (Table 4).  As expected, the 
collagenases and U32 peptidases of Streptococcal species shared the highest 
homology to gbscol1, ranging from 99%-82%.  It was found that gbscol1 had 
77% and 74% homology to Lactococcus lactis collagenase and Enterococcus 
faecium U32 peptidase, respectively.  It was also found that U32 peptidases from 
Listeria monocytogenes and Staphylococcus epidermidis had 63% and 49% 
homology, respectively. 
 Using the sequence of gbscol2 from S. agalactiae NEM316, a BLAST 
search was performed to compare it to other organisms (Table 5).  It was found 
that it shared high homology with other Streptococcal collagenases and 
peptidases of the U32 family:  79% homology with S. pyogenes, 76% homology 
with S. suis, 72% homology with Streptococcus pneumoniae and 67% 
Streptococcus thermophilus.  It was also found that it shared 56% homology with 
L. lactis and 55% homology with U32 peptidases from Enterococcus species.  
Lastly, it was found that gbscol2 had 30% homology to U32 peptidases from 
Bacillus species.   
  
Table 3.  smcol2 homologous genes 
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Table 4.  gbscol1 homologous genes 
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Table 5.  gbscol2 homologous genes 
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PCR Amplification and Cloning of the smcol2, gbscol1 and gbscol2 genes  
 
into the pBAD-TOPO Vector 
 
Using genomic DNA from S. mutans GS-5 as a template, PCR was used to 
amplify smcol2.  The primers were designed based on the sequenced genome of 
S. mutans UA159 (9) and the PCR product obtained was cloned into the pBAD 
TOPO® TA Cloning vector (Invitrogen).  The pBAD vector employs TOPO® 
Cloning, an easy and efficient method of cloning PCR products.  The linearized 
vector has 3’ deoxyribose thymidine (dT) overhangs that are complementary to 
the deoxyribose adenosine (dA) overhangs added by Taq polymerase to the 3’ 
end of PCR products.  This allows for the direct incorporation of PCR amplicons 
by Taq polymerase into the linearized plasmid vector.  With TOPO® Cloning, 
Topoisomerase I from Vaccinia virus is bound to the plasmid vector.  This 
enzyme binds duplex DNA at specific sites and cleaves the phosphodiester 
bonds on the vector backbone.  The energy generated from the broken 
phosphodiester backbone creates a high energy covalent bond between a tyrosyl 
residue of the enzyme and the phosphate residue of the cleaved DNA.  This 
leads to the release of Topoisomerase I through the attack of the phospho-tyrosyl 
bond between the enzyme and the DNA by the 5′ hydroxyl of the original cleaved 
strand.  PCR products cloned into pBAD are regulated for expression in E. coli.  
The expression of the PCR product in E. coli is determined by the araBAD 
promoter (pBAD). The pBAD-TOPO® plasmid encodes for the AraC gene 
product, which positively regulates this promoter.  The expression of the pBAD 
vector is controlled through the presence of L-arabinose.  When L-arabinose is 
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not present, transcription from pBAD is extremely low, while expression of pBAD 
is turned on in the presence of L-arabinose.  Protein expression levels can be 
optimized by varying the concentration of L-arabinose.   
Four primer sets were developed to amplify the gene with and without the 
signal peptide.   The gene was also amplified with and without the native stop.  In 
order to include the V5 epitope and the polyhistidine region of the pBAD vector, 
the native stop must be removed.  Once the PCR conditions were optimized for 
the four primer sets and the PCR product had been verified on agarose gel 
electrophoresis (Figure 5), it was cloned into the pBAD vector.    
The cloning reaction mixture was used to transform E. coli TOP10 cells.  After 
an overnight incubation, each primer set produced numerous transformants.   
Five ampicillin resistant (AmpR) transformants of each pBAD clone were chosen 
at random for further screening.  Plasmid DNA was isolated from the clones and 
the presence of the insert was verified through PCR using the above primers.  
Clones that produced plasmid that was positive for the corresponding PCR 
product were subjected to further testing.   
 Forward Primer Reverse Primer MW of PCR 
Product
Clone 1 Includes the signal peptide  Contains native stop 927 bp 
Clone 2 Includes the signal peptide Does not contain native stop 924 bp 
Clone 3 Excludes the signal peptide Contains native stop 702 bp 
Clone 4 Excludes the signal peptide Does not contain native stop 699 bp 
 
Table 6.  Primers designed for the cloning into the pBAD vector and the 
anticipated molecular weight of the amplified product 
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Once the insert had been confirmed to be present, the clones were analyzed 
to determine that the PCR product had been inserted in the correct orientation 
and were in frame with the C-terminal His tag.  pBAD # 1 only produced one 
clone that had the insert in the correct orientation, a band at 1106 bp (Figure 6A).  
This lone clone was used for further investigation.  Of the 5 clones screened, 
pBAD # 2 had two clones in the correct orientation which produced bands at 
1103 bp (Figure 6B).  Figure 6C shows pBAD # 3 and pBAD # 4 also had two 
clones, respectively, with the insert in the correct orientation and anticipated size; 
881 bp and 878 bp for pBAD # 3 and pBAD # 4, respectively.  Based on the PCR 
results, it was concluded that the smcol2 had been successfully cloned into the 
pBAD vector.  One clone that produced positive results for the PCR was 
randomly chosen for further analysis. 
The cloning of the gbscol1 and gbscol2 was as described for smcol2.  
Primers were designed based on the sequenced genome of S. agalactiae 
2603V/R and S. agalactiae NEM316 for the gbscol1 and gbscol2 gene.  Once 
PCR conditions had been optimized, the products were cloned in the pBAD 
vector (Figure 7). 
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Figure 5.  PCR results using S. mutans GS-5 genomic DNA and custom 
designed primers for smcol2 
A.  Lane 1:  Molecular weight standard 
Lane 2:  PCR product for pBAD clone # 1 = 927 bp 
B.  Lane 1:  Molecular weight standard 
Lane 2:  PCR product for pBAD clone # 2 = 924 bp 
C.  Lane 1:  Molecular weight standard 
Lane 2:  PCR product for pBAD clone # 3 = 702 bp 
Lane 3:  PCR product for pBAD clone # 4 = 699 bp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Confirmation of successful insertion and orientation of the smcol2 PCR 
products into the pBAD vector using pBAD forward primer and the insert’s 
reverse primer 
A.  Lane 1:  Molecular weight standard 
Lane 2:  PCR conformation for pBAD clone # 1 = 1106 bp 
B.  Lane 1:  Molecular weight standard 
Lane 2:  PCR confirmation for pBAD clone # 2a = 1103 bp 
Lane 3:  PCR confirmation for pBAD clone # 2b = 1103 bp 
C.  Lane 1:  Molecular weight standard 
Lane 2:  PCR confirmation for pBAD clone # 3a = 881 bp 
Lane 3:  PCR confirmation for pBAD clone # 3b = 881 bp 
Lane 4:  PCR confirmation for pBAD clone # 4a = 878 bp 
Lane 5:  PCR confirmation for pBAD clone # 4b = 878 bp 
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Figure 7.  PCR results using S. agalactiae USF704 genomic DNA and 
custom- designed primers for gbscol1 and gbscol2 
Lane 1:  Molecular weight standard 
Lane 2:  PCR product for gbscol1 = 1284 bp 
Lane 3:  PCR product for gbscol2 = 924 bp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8:  PCR confirmation of successful insertion in the pBAD vector 
Figure 8A and 8C:  Top lanes show plasmid isolated from pBAD/gbscol1 transformants.  
The bottom lanes show PCR using the pBAD forward primer with the above 
corresponding plasmid.  Lanes 2 and 3 show bands at 1463 bp. 
Figure 8B and 8D:  Top lanes show plasmid isolated from pBAD/gbscol2 transformants.  
The bottom lanes show PCR using the pBAD forward primer with the above 
corresponding plasmid.  Lanes 8 and 11 show bands at 1103 bp. 
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Plasmid DNA was isolated from the clones (Figure 8, top) and the presence 
of the insert was verified through PCR using the primers specific for the insert. 
Clones that showed a band at 1284 bp for pBAD/gbscol1 and 924 bp for 
pBAD/gbscol2 were analyzed to determine whether the insert had been inserted 
in the correct orientation.  Gbscol1 and Gbscol2 transformants both showed two 
clones that had the insert positioned in the correct orientation (Figure 8, bottom).  
These results show that the gbscol1 and gbscol2 had been successfully cloned 
into the pBAD vector.  One of each clone was chosen at random for further 
studies. 
 
 
 
Expression and Detection of pBAD/smcol2 through induction with 
Arabinose, SDS-PAGE and Western Blot 
Pilot expression experiments were performed on pBAD/smcol2 clone # 2, 
pBAD/smcol2 clone # 4, pBAD/gbscol1 and pBAD/gbscol2 to determine the 
optimal concentration of arabinose for induction of the clones and the expression 
of the recombinant protein.  pBAD/smcol2 clone # 2 will be referred to as 
smcol2sp (smcol2 with signal peptide) and pBAD/smcol2 clone # 4 will be 
referred to as smcol2wosp (smcol2 without signal peptide) throughout the rest of 
the paper.  It was found that the highest production of the recombinant protein in 
the clones was with 0.2% arabinose.  0.2% arabinose was then used for all 
subsequent experiments as the inducer concentration. 
A Western blot was performed on clones smcol2sp, smcol2wosp, gbscol1 
and gbscol2 using an anti-HisG antibody to definitely verify the size and the 
production of the fusion protein in the corresponding induced recombinant 
bacteria.  As expected, smcol2sp clone produced a strong band at 40 kDa and 
smcol2wosp clone produced a smaller band at 31 kDa (Figure 9).  The negative 
control (E. coli TOP10 transformed with pBAD-empty vector) showed no 
reactivity to the anti-HisG antibody.  The gbscol1 clone showed a strong band at 
52.5 kDa whereas gbscol2 showed a band at about 40 kDa.  This data confirms 
that the four clones did produce successful induction of the polyhistidine (6xHis) 
tagged fusion protein. 
 
 
 
 
 
 
 
 
 
Figure 9:  Western Blot of smcol2sp and smcol2wosp 
Lane 1:  Molecular weight standard 
Lane 2:  smcol2sp, 40 kDA  
Lane 3:  smcol2wosp; 31 kDA  
Lane 4:  Negative control, pBAD empty vector 
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Purification of the polyhistidine (6xHis) tagged fusion proteins smcolsp,  
smcolwosp, gbscol1 and gbscol2 
A large-scale induction was performed on the four clones using 0.2% 
arabinose.  The presence of the recombinant protein in the induced cells was 
verified through immunodot analysis using anti-HisG antibody (Figure 10) before 
isolation.  The recombinant protein was then isolated from the cells via Qiagen’s 
NI-NTA Fast Start Columns (Catalog # 30600) using native conditions.  The 
samples were separated by electrophoresis on an SDS-PAGE gel to confirm that 
the protein of the correct size was isolated (Figure 11).  The purified enzymes 
were then verified to be the correct poly-histamine fusion recombinant protein 
through Western Blot analysis using anti-HisG antibody.  Bands with the 
anticipated molecular size were observed: 40 kDa smcol2sp, 31 kDa 
smcol2wosp, 52.5 kDa gbscol1and 40 kDa gbscol2 on both the SDS-PAGE and 
Western Blot (Figure 12).  A Bradford assay was then performed to determine 
the concentration of the isolated proteins.  It was found that the protein 
concentration of each sample was as follows: smcol2sp, 559.8 ug/ml; 
smcol2wosp, 580.9 ug/ml; gbscol1, 613.8 ug/ml; gbscol2, 538.9 ug/ml.  These 
samples were analyzed for collagenase activity. 
pBAD Clones Size of protein (kDa ) pI
smcol2sp 40 kDa 5.48 
smcol2wosp 31 kDa 5.62 
gbscol1 52.5 kDa 5.46 
gbscol2 40 kDa 5.28 
 
Table 7.  pBAD clones and the anticipated protein size, including the pBAD 
vector, and pI 
 
 
 
 
 
 
 
 
 
 
Figure 10:  Immunodot of induced clones   
Well 1:  smcol2sp 
Well 2:  smcol2wosp  
Well 3:  gbscol1 
Well 4:  gbscol2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11:  SDS-PAGE of purified recombinant enzymes 
Lane 1:  Molecular weight standard 
Lane 2:  Purified smcol2sp, 40 kDa 
Lane 3:  Purified smcol2wosp, 31 kDa 
Lane 4:  Purified gbscol1, 52.5 kDa 
Lane 5:  Purified gbscol2, 40 kDa 
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Figure 12:  Western Blot of purified enzymes 
A.  Lane 1:  Molecular weight standard 
Lane 2:  Negative control 
Lane 3:  Purified smcol2sp, 40 kDa 
B.  Lane 1:  Molecular weight standard 
Lane 2:  Negative control 
Lane 3:  Purified smcol2wosp, 31 kDa 
C.  Lane 1:  Molecular weight standard 
Lane 2:  Negative control 
Lane 3:  Purified gbscol1, 52.5 kDa 
D.  Lane 1:  Molecular weight standard 
Lane 2:  Negative control 
Lane 3:  Purified gbscol2, 40 kDa 
 
 
 
Gelatinase Assay 
 
     All the samples tested, which included pure recombinant smcol2sp, 
smcol2wosp, gbscol1 and gbscol2, were positive for gelatinase activity (Figure 
13).  As anticipated C. histolyticum collagenase, and trypsin, used as positive 
controls, also degraded the gelatin.   No gelatinase activity was observed with a 
BSA dot.  
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Figure 13.  Gelatinase assay using X-Ray film 
Top row: smcol2sp; smcol2wosp 
Middle row: gbscol1; gbscol2 
Bottom row: C. histolyticum collagenase; Trypsin 
. 
 
 
Blue Collagenase Assay  
The Blue Collagenase Assay was used to determine whether or not the 
recombinant proteins had true collagenase activity. As anticipated, C histolyticum 
was strongly positive, whereas trypsin was negative (Figure 14). All recombinant 
enzymes showed the presence of small collagen fragments adhering to the wall 
of the tube (Figure 14).  However, only smcol2sp and gbscol2 (also with the 
signal peptide) showed some measurable degraded collagen (OD500nm)       
(Table 8).   
 
 
Samples gbscol1 gbscol2 smcol2sp smcol2wosp C. histolyticum Trypsin 
Abs OD500 0.0472 0.1237 0.1965 0.034 1.0985 0.075 
Abs OD500 0.0728 0.2268 0.1467 0.0705 0.913 0.015 
Mean 0.060 0.175 0.1716 0.052 1.006 0.045 
SD 0.018 0.072 0.035 0.025 0.130 0.042 
Table 8.  Raw Data from Blue Collagenase Assay 
        1          2            3              4 5           6          7          8      9     10 
 
 
 
 
 
     
 
 
 Figure 14.  Blue collagenase assay 
C. histolyticum collagenase (1) showing digestion of blue collagen 
Trypsin (2) showing no degradation of collagen 
Partial degradation of collagen into smaller fragments sticking to the tube wall 
gbscol1 (3 & 4); gbscol2 (5 & 6); smcol2sp (7 & 8); smcol2wosp (9 & 10) 
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Figure 15:  Results of Blue Collagenase Assay 
Mean OD500nm of duplicate samples of: 
1. Gbscol1 
2. Gbscol2 
3. Smcol2sp 
4. Smcol2wosp 
5. C. histolyticum collagenase 
6. Trypsin 
The absorbance observed with samples 1, 4 and 6 is equal to the background   
level observed with blue collagen incubated in parallel with assay buffer alone.  
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DISCUSSION 
 
 
With the recent availability of completely sequenced microbial genomes, 
analysis of S. mutans and GBS genomic sequences allowed the identification of 
putative collagenase genes in these organisms. Of the putative collagenases 
identified in S. mutans UA159, one identical gene (smcol1) was previously 
cloned from S. mutans GS-5 and sequenced  (21).  Bioinformatical analysis of 
the second putative collagenase gene, smcol2, indicated the possibility of it being 
also a U32 collagenase. Homologous genes in GBS were identified in two S. 
agalactiae strains NEM316 and 2603V/R.  Subsequently, primers were designed 
for the amplification of these genes using genomic DNA as a template.  The PCR 
products obtained were then cloned into an inducible vector system that allowed 
for strict regulation of recombinant protein expression.   
 Recombinant clones harboring the genes of interest in the right orientation 
were obtained and confirmed by PCR analysis, and the optimal recombinant 
protein expression was achieved by induction with 0.2% arabinose. Expression 
of the 6xHis-tagged fusion proteins was confirmed by western immunoblot 
analysis. SDS-PAGE and Western blot analysis of smcol2sp and smcol2wosp 
indicated that the presence of the signal peptide did not interfere with protein 
expression.  Hence, subsequent cloning of GBS collagenases was conducted 
without removal of the signal peptide.   
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 As anticipated from His-tagged fusion protein, the purification of recombinant 
proteins was much facilitated, and pure proteins were obtained and used in 
determining their enzymatic activity.  Previously, gelatinase activity was observed 
with C. histolyticum collagenase (31), S. mutans (22) and GBS (23) but not with 
P. gingivalis prtC collagenase (27). In the present study, gelatinase activity was 
demonstrated for pure recombinant S. mutans and GBS recombinant enzymes, 
thus indicating that these enzymes were not serine proteases like trypsin as they 
were not inhibited by PMSF.  Since prtC collagenase was reported not to 
degrade gelatin, the observation of gelatinase activity in S. mutans and GBS 
enzymes denoted that members of the U32 family of peptidases/collagenases 
were heterogeneous. 
It was shown that these three enzymes, smcol2, gbscol1 and gbscol2, had 
high degree of homology with other bacterial protease, most being U32 
peptidases and collagenases (Tables 4, 5 and 6).  Based on the ProtoMap 
database (46) all three enzymes were classified as members of the cluster, 1872.  
This cluster contains 24 members, with 13 containing the Peptidase family U32 
signature   It was also found that the European Molecular Biology Laboratory 
(EMBL) database (1) grouped these proteins into family ENZYME: 3.4.-.- (E.C. 
3.4), which are peptide hydrolases, acting on peptide bonds. This family contains 
other well known collagenases from Vibrio alginolyticus and C. histolyticum.   
 Complete degradation of blue collagen by C. histolyticum collagenase and the 
lack of digestion by trypsin demonstrated that the blue collagen substrate 
prepared in our laboratory was useful in determining true collagenase activity.   
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Generation of smaller fragments upon incubation with the recombinant proteins 
indicated the presence of enzymes degrading partially the blue collagen 
substrate, even when the incubation time was extended to 72 hours.  Only the 
smcol2sp and gbscol2 had the ability to degrade completely some of the 
collagen.  This apparent difference may be due to the fact that the C. histolyticum 
collagenase sample contained a mixture of collagenases and proteases, or that 
the 6x His-Tag might interfere with collagenase activity.  Interestingly, smcol2sp 
protein showed some complete collagenase activity, but not the smcol2wosp. 
Considering that collagenase activity was observed with P. gingivalis bacteria, 
but not with purified prtC enzyme, and that collagenase activity involved two 
enzymes (20), it is hypothesized that perhaps the same holds true for the S. 
mutans and GBS  col1 and col2 enzymes.    
Prior to the present study, a major obstacle was encountered due to the lack 
of a true collagenase assay.  Synthetic peptide substrate, acid soluble collagen 
and denatured collagen used in commercially available collagenase assay kits 
were found not to be specific for collagenase as none contained the typical triple 
helix of native type I collagen (17).  By using the specific blue collagenase assay 
developed in our laboratory, we were able to observe complete and incomplete 
collagen degradation activity by col1 and col2 in S. mutans and GBS.  Since the 
recombinant enzymes contained the signal peptide and the 6xHis-Tag, it is not 
possible to extrapolate the data to the native enzymes, which may very well be 
more active than the recombinant fusion proteins.  Nevertheless, the data 
obtained in the present study already showed that the S. mutans and GBS 
 49
collagenases, col1 and col2, had both collagenase and gelatinase activity, and 
that they appeared to be distinct from both C. histolyticum collagenase and P. 
gingivalis collagenase.  Indeed, genetic analysis indicated that smcol1, smcol2, 
gbscol1 and gbscol2 had essentially no homology to C. histolyticum 
collagenases and moderate homology to P. gingivalis prtC enzymes.  This is in 
agreement with the distinct differences between bacterial Zn-metalloproteases 
and U32 peptidases/collagenases, and the heterogeneity among members of the 
U32 family. 
In conclusion, the work presented herein has significantly added to our 
understanding of S. mutans and GBS in dental root decay and premature rupture 
of the amniochorionic membrane, and provided the direction for future studies.  
Work is already underway in our laboratory by other members of our research 
team to inactivate smcol1, smcol2, gbscol1 and gbscol2 by allelic exchange in S. 
mutans and GBS to probe whether or not both enzymes are needed for 
collagenase expression in the respective bacteria, to clone these genes into a 
vector that will allow the purification of native enzymes for in vitro studies, and to 
analyze collagenase expression as a function of growth state, planktonic versus 
biofilms and to identify genes that are similarly regulated by microarray analysis.       
. 
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